[go: up one dir, main page]

CA2396036A1 - Composes pour l'immunotherapie et le diagnostic du cancer du colon et procedes d'utilisation - Google Patents

Composes pour l'immunotherapie et le diagnostic du cancer du colon et procedes d'utilisation Download PDF

Info

Publication number
CA2396036A1
CA2396036A1 CA002396036A CA2396036A CA2396036A1 CA 2396036 A1 CA2396036 A1 CA 2396036A1 CA 002396036 A CA002396036 A CA 002396036A CA 2396036 A CA2396036 A CA 2396036A CA 2396036 A1 CA2396036 A1 CA 2396036A1
Authority
CA
Canada
Prior art keywords
seq
cdna sequence
determined cdna
clone
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002396036A
Other languages
English (en)
Inventor
Jiangchun Xu
Michael J. Lodes
Heather Secrist
Darin R. Benson
Madeleine Joy Meagher
John A. Stolk
Gordon E. King
Tongtong Wang
Yuqiu Jiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2396036A1 publication Critical patent/CA2396036A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002396036A 1999-12-30 2000-12-29 Composes pour l'immunotherapie et le diagnostic du cancer du colon et procedes d'utilisation Abandoned CA2396036A1 (fr)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US47629699A 1999-12-30 1999-12-30
US09/476,296 1999-12-30
US48032100A 2000-01-10 2000-01-10
US09/480,321 2000-01-10
US50462900A 2000-02-15 2000-02-15
US09/504,629 2000-02-15
US51944400A 2000-03-06 2000-03-06
US09/519,444 2000-03-06
US57525100A 2000-05-19 2000-05-19
US09/575,251 2000-05-19
US60944800A 2000-06-29 2000-06-29
US09/609,448 2000-06-29
US64981100A 2000-08-28 2000-08-28
US09/649,811 2000-08-28
PCT/US2000/035596 WO2001049716A2 (fr) 1999-12-30 2000-12-29 Composes pour l'immunotherapie et le diagnostic du cancer du colon et procedes d'utilisation

Publications (1)

Publication Number Publication Date
CA2396036A1 true CA2396036A1 (fr) 2001-07-12

Family

ID=27569804

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002396036A Abandoned CA2396036A1 (fr) 1999-12-30 2000-12-29 Composes pour l'immunotherapie et le diagnostic du cancer du colon et procedes d'utilisation

Country Status (4)

Country Link
EP (1) EP1242598A2 (fr)
AU (1) AU2608201A (fr)
CA (1) CA2396036A1 (fr)
WO (1) WO2001049716A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962779B1 (en) 1998-10-02 2005-11-08 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
AU6459601A (en) * 2000-05-15 2001-11-26 Univ Emory Novel dual oxidases as mitogenic and endocrine regulators
JP2004512023A (ja) * 2000-06-09 2004-04-22 コリクサ コーポレイション 結腸癌の治療および診断のための組成物および方法
US6635750B1 (en) * 2000-07-20 2003-10-21 Millennium Pharmaceuticals, Inc. B7-H2 nucleic acids, members of the B7 family
AU2001285568A1 (en) * 2000-07-28 2002-03-22 Michael Andrew Mcguckin Mucin
AU2001294999A1 (en) * 2000-08-07 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
AU784548B2 (en) * 2001-03-16 2006-04-27 Ortho-Clinical Diagnostics, Inc. Reg-like protein
AU2002353972A1 (en) * 2001-11-02 2003-05-19 Pfizer Products Inc. Lung cancer therapeutics and diagnostics
GB0130720D0 (en) * 2001-12-21 2002-02-06 Serono Internat S A Proteins
DE10230631A1 (de) * 2002-07-02 2004-01-22 Metagen Pharmaceuticals Gmbh Verwendungen von an Ngal bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen
TWI340168B (en) * 2003-05-07 2011-04-11 Tosoh Corp Method of detecting micrometastasis
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US8535677B2 (en) 2006-06-06 2013-09-17 Oxford Biotherapeutics, Ltd. Antibody drug conjugate treatment of colorectal cancer
EP2078202B1 (fr) * 2006-08-29 2017-03-08 Oxford BioTherapeutics Ltd Protéine
US9181339B2 (en) 2009-04-20 2015-11-10 Oxford Bio Therapeutics Ltd. Antibodies specific to cadherin-17

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041289A (en) * 1987-11-13 1991-08-20 Becton Dickinson And Company Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells
AU7499198A (en) * 1997-05-21 1998-12-11 Johns Hopkins University, The Gene expression profiles in normal and cancer cells
CA2294705A1 (fr) * 1997-07-01 1999-01-14 Human Genome Sciences, Inc. 19 proteines secretees par l'etre humain
US5929033A (en) * 1998-02-10 1999-07-27 Incyte Pharmaceuticals, Inc. Extracellular mucous matrix glycoprotein
US6183968B1 (en) * 1998-03-27 2001-02-06 Incyte Pharmaceuticals, Inc. Composition for the detection of genes encoding receptors and proteins associated with cell proliferation
CA2328128A1 (fr) * 1998-05-21 1999-11-25 Diadexus Llc Nouveau procede de diagnostic, de surveillance et de stadification du cancer du colon
IL139686A0 (en) * 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000021991A1 (fr) * 1998-10-15 2000-04-20 Genetics Institute, Inc. ETIQUETTES DE SEQUENCES EXPRIMEES SECRETEES (sESTs)
JP2002533082A (ja) * 1998-12-23 2002-10-08 コリクサ コーポレイション 結腸癌の免疫療法および診断のための化合物およびそれらの使用のための方法
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
CA2373915A1 (fr) * 1999-06-02 2000-12-07 Genentech, Inc. Procedes et compositions visant a inhiber la proliferation des cellules cancereuses
JP2005503751A (ja) * 1999-12-10 2005-02-10 インサイト・ゲノミックス・インコーポレイテッド 細胞外マトリックスおよび細胞接着分子

Also Published As

Publication number Publication date
WO2001049716A3 (fr) 2002-01-31
EP1242598A2 (fr) 2002-09-25
AU2608201A (en) 2001-07-16
WO2001049716A2 (fr) 2001-07-12

Similar Documents

Publication Publication Date Title
EP1169347B1 (fr) Composes et procedes de therapie et de diagnostic du cancer du poumon
EP1183348B1 (fr) Compositions pour le traitement et le diagnostic du cancer du sein et leurs procedes d'utilisation
EP1141290B1 (fr) Compositions et procedes destines a la therapie et au diagnostic du cancer de l'ovaire
US6444425B1 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2001276973B2 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
EP1870466A2 (fr) Compositions et procédés pour le traitement et le diagnostic du cancer de la prostate
WO2002083070A2 (fr) Composes pour l'ummunotherapie et le diagnostic du cancer du colon et methodes d'utilisation associees
CA2356987A1 (fr) Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
AU2001276973A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
US20010055596A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
CA2396036A1 (fr) Composes pour l'immunotherapie et le diagnostic du cancer du colon et procedes d'utilisation
JP2002540789A5 (fr)
US6623923B1 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2001051513A2 (fr) Sequences associees a une tumeur ovarienne
US20020048759A1 (en) Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
US20050260177A1 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
NZ567750A (en) Compositions and uses for cancer therapy
US20020110547A1 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US20020076414A1 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US6933363B1 (en) Compositions and methods for therapy and diagnosis of lung cancer
US6489101B1 (en) Compositions and methods for therapy and diagnosis of breast cancer
US20020182191A1 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US20020155125A1 (en) Compositions and methods for therapy and diagnosis of breast cancer
US20030194764A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003271300B2 (en) Compositions and methods for therapy and diagnosis of ovarian cancer

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued